![](/img/cover-not-exists.png)
Pegylated interferon alpha – 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial
Gowin, K., Jain, T., Kosiorek, H., Tibes, R., Camoriano, J., Palmer, J., Mesa, R.Volume:
54
Language:
english
Journal:
Leukemia Research
DOI:
10.1016/j.leukres.2017.01.006
Date:
March, 2017
File:
PDF, 477 KB
english, 2017